Abstract
Fibromyalgia is an enigmatic medical condition whose specific etiology remains undiscovered but currently plagues five million Americans [1]. Research indicates that the origin of the disease is most likely multifactorial. Treatment should therefore be tailored accordingly. Thus, it is often necessary to combine different options in order to achieve the maximum benefit in patients suffering from fibromyalgia.
Keywords: Fibromyalgia, Treatment, Pain, Sleep, Serotonin, Antidepressants, SSRIs, HPA, Estrogen
Current Pharmaceutical Design
Title: Combination Therapy in Fibromyalgia
Volume: 12 Issue: 1
Author(s): A. H. Clayton and S. G. West
Affiliation:
Keywords: Fibromyalgia, Treatment, Pain, Sleep, Serotonin, Antidepressants, SSRIs, HPA, Estrogen
Abstract: Fibromyalgia is an enigmatic medical condition whose specific etiology remains undiscovered but currently plagues five million Americans [1]. Research indicates that the origin of the disease is most likely multifactorial. Treatment should therefore be tailored accordingly. Thus, it is often necessary to combine different options in order to achieve the maximum benefit in patients suffering from fibromyalgia.
Export Options
About this article
Cite this article as:
Clayton H. A. and West G. S., Combination Therapy in Fibromyalgia, Current Pharmaceutical Design 2006; 12 (1) . https://dx.doi.org/10.2174/1381612810606010011
DOI https://dx.doi.org/10.2174/1381612810606010011 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Omega-3 Fatty Acid Treatment Combined with Chemotherapy to Prevent
Toxicity, Drug Resistance, and Metastasis in Cancer
Current Drug Targets A Clinician’s Guide to Monoamine Oxidase Inhibitors
Current Psychiatry Reviews Peptides Targeting Gap Junctional Structures
Current Pharmaceutical Design Physical Activity, Insulin Action, and Diabetes Prevention and Control
Current Diabetes Reviews Aldose Reductase Inhibitors and Nanodelivery of Diabetic Therapeutics
Mini-Reviews in Medicinal Chemistry Clinical Implication of Meissner’s Corpuscles
CNS & Neurological Disorders - Drug Targets Withdrawal Notice: Mucoadhesive Microspheres: An Emerging Trends in Therapy of Diabetes Mellitus
Current Diabetes Reviews Mechanisms and Treatment of Neuropathic Pain
Central Nervous System Agents in Medicinal Chemistry Competitive Gly/NMDA Receptor Antagonists
Current Topics in Medicinal Chemistry Monogenic Diabetes: Genetics and Relevance on Diabetes Mellitus Personalized Medicine
Current Diabetes Reviews Beyond Mitochondria, What Would be the Energy Source of the Cell?
Central Nervous System Agents in Medicinal Chemistry Antihyperglycemic Effects of Formulation of Spray Dried Fruit Juice of Emblica officinalis in Streptozotocin Induced Diabetic Rats.
Current Nutrition & Food Science TRP Channels in Respiratory Pathophysiology: the Role of Oxidative, Chemical Irritant and Temperature Stimuli
Current Neuropharmacology Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Genus Calotropis: A Hub of Medicinally Active Phytoconstituents
Current Traditional Medicine Receptor-Based Design of Cytokine Therapeutics
Current Pharmaceutical Biotechnology Towards Newer Molecular Targets for Chronic Diabetic Complications
Current Vascular Pharmacology Subject Index To Volum 2
Current Diabetes Reviews From French Paradox to Cancer Treatment: Anti-cancer Activities and Mechanisms of Resveratrol
Anti-Cancer Agents in Medicinal Chemistry Transient Receptor Potential Vanilloid 1 Channel Modulation: A Novel Approach to Pain Therapy
Current Bioactive Compounds